Evidence map›Paper›PMID 38966545›Full record

ArticleFrontiers in pharmacology2024

CaMKIIδ-dependent dysregulation of atrial Na

Philipp Hegner, Florian Ofner, Benedikt Schaner, Mathias Gugg, Maximilian Trum, Anna-Maria Lauerer, Lars Siegfried Maier, Michael Arzt, Simon Lebek, Stefan Wagner

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Increased MyocardialInternational journal of molecular sciences · 2025
    Article
  2. MyocardialAntioxidants (Basel, Switzerland) · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Philipp HegnerDepartment of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.
Florian OfnerDepartment of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.
Benedikt SchanerDepartment of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.
Mathias GuggDepartment of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.
Maximilian TrumDepartment of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.
Anna-Maria LauererDepartment of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.
Lars Siegfried MaierDepartment of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.
Michael ArztDepartment of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.
Simon Lebek *Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.
Stefan Wagner *Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Obstructive sleep apnea (OSA) has been linked to various pathologies, including arrhythmias such as atrial fibrillation. Specific treatment options for OSA are mainly limited to symptomatic approaches. We previously showed that increased production of reactive oxygen species (ROS) stimulates late sodium current through the voltage-dependent Na Objective: We analyzed the effects of OSA on ROS production, cytosolic Na Methods: OSA was induced in C57BL/6 wild-type and CaMKIIδ-knockout mice by polytetrafluorethylene (PTFE) injection into the tongue. After 8 weeks, their atrial cardiomyocytes were analyzed for cytosolic and mitochondrial ROS production via laser-scanning confocal microscopy. Quantifications of the cytosolic Na Results: PTFE treatment resulted in increased cytosolic and mitochondrial ROS production. Importantly, the cytosolic Na Conclusion: Atrial Na

Indexed as

CaMKIIδcardiac arrhythmiasNa+ homeostasisobstructive sleep apneareactive oxygen speciessleep-disordered breathing

Identifiers

PMID38966545
PMCPMC11222670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.